Xiaoxiao Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Xiaoxiao Xu has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Jie Tan
Department of Pediatric Outpatient Chongqing Health Center for Women and Children Chongqing China
1 shared publication Lianxiu Su
Department of Pathology, Guigang City People's Hospital The Eighth Affiliated Hospital of Guangxi Medical University Guigang Guangxi PR China
1 shared publication- Mohamed E. A. Abdelrahim
Clinical Pharmacy Department, Faculty of Pharmacy, Beni-suef University, Beni-suef, Egypt
1 shared publication - Rong Li
Education Department of Guangxi Zhuang Autonomous Region, Key Laboratory of Environmental Pollution and Integrative Omics Guilin Medical University Guilin China
1 shared publication Shaoqing Chai
Department of Pediatrics Inner Mongolia People's Hospital Hohhot City Inner Mongolia China
1 shared publication- Wenjun Huang
Key Laboratory of Environmental Pollution and Integrative Omics, Guilin Medical University, Education Department of Guangxi Zhuang Autonomous Region, Guilin, China
1 shared publication
Latest Publications
- Open Access
- 1 August 2021
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 75 (10) , e14640
Effect of age of COVID‐19 inpatient on the severity of the disease: A meta‐analysis
Background Clinical symptoms of adults and paediatric inpatients with COVID-19 disease are conflicting. This meta-analysis was conducted to assess the effect of age of COVID-19 inpatient on the severity of the disease. Methods A systematic literature search up to January 2021 was performed and 5 studies included 910 inpatients with COVID-19 disease at the baseline of the study; 773 of them were adult inpatients, and 137 of them were paediatric inpatients. They reported a comparison between adults and children with COVID-19 in the level of symptomatic severity, clinical features, computed tomography (CT) results and laboratory results. Odds ratio (OR) with 95% confidence intervals (CIs) were calculated assessing the effect of age of COVID-19 inpatient on the severity of the disease using the dichotomous method with a random or fixed-effect model. Results Adults with COVID-19 disease had significantly lower number of mild cases (OR, 0.18; 95% CI, 0.04-0.77, P = .02); higher number severe cases (OR, 4.90; 95% CI, 2.03-11.83, P < .001); higher number of cases with fever (OR, 4.14; 95% CI, 2.31-7.43, P < .001); and higher number of cases with CT positive COVID-19 disease (OR, 2.04; 95% CI, 1.17-3.55, P = .001) compared with children. However, no significant difference was found between adults and children in number of cases with shortness of breath (OR, 1.44; 95% CI, 0.41-5.04, P = .57); dry cough (OR, 1.77; 95% CI, 0.64-4.93, P = .27); leukopenia (OR, 0.89; 95% CI, 0.47-1.66, P = .71); lymphopenia (OR, 0.96; 95% CI, 0.49-1.88, P = .91); high platelets (OR, 0.41; 95% CI, 0.17-1.02, P = .05); and high D-dimer (OR, 0.82; 95% CI, 0.43-1.56, P = .54). Conclusions Adults with COVID-19 disease have a much higher level of symptomatic severity, fever and CT-positive COVID-19 disease than children. However, as shown in our results, the laboratory data were similar in both groups.
- 1 August 2021
- Published by Wiley in International Journal Of Clinical Practice
- Vol. 75 (10) , e14640
Open AccessEffect of age of COVID‐19 inpatient on the severity of the disease: A meta‐analysis
Background Clinical symptoms of adults and paediatric inpatients with COVID-19 disease are conflicting. This meta-analysis was conducted to assess the effect of age of COVID-19 inpatient on the severity of the disease. Methods A systematic literature search up to January 2021 was performed and 5 studies included 910 inpatients with COVID-19 disease at the baseline of the study; 773 of them were adult inpatients, and 137 of them were paediatric inpatients. They reported a comparison between adults and children with COVID-19 in the level of symptomatic severity, clinical features, computed tomography (CT) results and laboratory results. Odds ratio (OR) with 95% confidence intervals (CIs) were calculated assessing the effect of age of COVID-19 inpatient on the severity of the disease using the dichotomous method with a random or fixed-effect model. Results Adults with COVID-19 disease had significantly lower number of mild cases (OR, 0.18; 95% CI, 0.04-0.77, P = .02); higher number severe cases (OR, 4.90; 95% CI, 2.03-11.83, P < .001); higher number of cases with fever (OR, 4.14; 95% CI, 2.31-7.43, P < .001); and higher number of cases with CT positive COVID-19 disease (OR, 2.04; 95% CI, 1.17-3.55, P = .001) compared with children. However, no significant difference was found between adults and children in number of cases with shortness of breath (OR, 1.44; 95% CI, 0.41-5.04, P = .57); dry cough (OR, 1.77; 95% CI, 0.64-4.93, P = .27); leukopenia (OR, 0.89; 95% CI, 0.47-1.66, P = .71); lymphopenia (OR, 0.96; 95% CI, 0.49-1.88, P = .91); high platelets (OR, 0.41; 95% CI, 0.17-1.02, P = .05); and high D-dimer (OR, 0.82; 95% CI, 0.43-1.56, P = .54). Conclusions Adults with COVID-19 disease have a much higher level of symptomatic severity, fever and CT-positive COVID-19 disease than children. However, as shown in our results, the laboratory data were similar in both groups.
- 13 May 2019
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 120 (9) , 16153-16159
Endocrinological characterization of pancreatic ducts in HFD and HGD fed mice
Our previous findings show that insulin‐produced cells are found in human pancreatic ducts. However, the underlying molecular mechanism of transdifferentiation in pancreatic ductal cells is not yet totally uncovered. High‐fat diet (HFD) and high‐glucose diet (HGD) fed mice were subjected to the biochemical tests in sera. And the pancreatic samples were used for immunostaining and immunoblotting assays, respectively. These serological findings showed that fasting blood glucose, insulin, blood lipids (triglyceride, total cholesterol), liver functional enzymes (glutamic‐oxaloacetic transaminase, glutamic‐pyruvic transaminase) were increased in HFD fed mice. Immunostaining observations showed that insulin protein was positively expressed in pancreatic islets and ducts, characterized with elevated immunoreactive cells of insulin, neurogenin‐3, poly (ADP‐ribose) polymerase (PARP), and reduced F‐box/WD repeat‐containing protein 7‐positive cells in pancreatic islets and ducts of HFD and HGD fed mice. Interestingly, immunoblotting assays suggested that intrapancreatic expressions of insulin, Krüppel‐like Factor 2, PARP, p42/44MAPK proteins were upregulated in HFD and HGD exposed mice, while Fbxw7 protein content in pancreas samples were reduced. Taken together, the current findings reveal that there may be potential transdifferentiation of insulin‐producing cells in pancreatic ducts through inducing a pathway of intracellular Fbxw7 ubiquitination.
- 13 May 2019
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 120 (9) , 16153-16159
Endocrinological characterization of pancreatic ducts in HFD and HGD fed mice
Our previous findings show that insulin‐produced cells are found in human pancreatic ducts. However, the underlying molecular mechanism of transdifferentiation in pancreatic ductal cells is not yet totally uncovered. High‐fat diet (HFD) and high‐glucose diet (HGD) fed mice were subjected to the biochemical tests in sera. And the pancreatic samples were used for immunostaining and immunoblotting assays, respectively. These serological findings showed that fasting blood glucose, insulin, blood lipids (triglyceride, total cholesterol), liver functional enzymes (glutamic‐oxaloacetic transaminase, glutamic‐pyruvic transaminase) were increased in HFD fed mice. Immunostaining observations showed that insulin protein was positively expressed in pancreatic islets and ducts, characterized with elevated immunoreactive cells of insulin, neurogenin‐3, poly (ADP‐ribose) polymerase (PARP), and reduced F‐box/WD repeat‐containing protein 7‐positive cells in pancreatic islets and ducts of HFD and HGD fed mice. Interestingly, immunoblotting assays suggested that intrapancreatic expressions of insulin, Krüppel‐like Factor 2, PARP, p42/44MAPK proteins were upregulated in HFD and HGD exposed mice, while Fbxw7 protein content in pancreas samples were reduced. Taken together, the current findings reveal that there may be potential transdifferentiation of insulin‐producing cells in pancreatic ducts through inducing a pathway of intracellular Fbxw7 ubiquitination.